Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
Article Options
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
Gastrointestinal Stromal Tumor - Experience From A Tertiary Care Center
Kalidas Biswas1, Jayanta Kumar Das2, Swarnabindu Banerjee3, Shibashish Bhattacharyya3, Bishan Basu4, Shibajyoti Ghosh5
1Department of  Medical Gastroenterology, 2Department of  Anaesthesiology, 3Department of  Medical Oncology, 4Department of  Radiotherapy, 5Department of  Surgery, Calcutta National Medical College & Hospital, Kolkata

Corresponding Author
Dr Swarnabindu Banerjee 


Gastrointestinal stromal tumor( GIST ) is an uncommon entity in clinical practice. Though It is the commonest mesenchymal smooth muscle tumor, it accounts for only  <1% of all GI malignancies. Any part of  gastrointestinal tract (GIT ) may be involved . Stomach is the commonest site for this tumor. Other sites of GIT  are also affected in this disease. Increasing awareness, newer diagnostic modalities and novel chemotherapeutic agents make the disease diagnosed earlier  and successfully treated . Imatinib mesylate has changed the outcome of the disease .In Eastern part of India we have seen some cases over the years and expressed our observation here . Most of the patients were operated and later required Imatinib